How Is Receptor Activator of Nuclear Factor-κβ/Receptor Activator of Nuclear Factor-κβ Ligand Targeting Ranked as an Immuno-Oncology Target for NSCLC: a Pathway Unclear as yet?

J Thorac Oncol

Cross Cancer Institute, University of Alberta, Edmonton, Alberta, Canada. Electronic address:

Published: October 2020

Download full-text PDF	Source
http://dx.doi.org/10.1016/j.jtho.2020.07.011	DOI Listing

Publication Analysis

activator nuclear

receptor activator

nuclear factor-κβ/receptor

factor-κβ/receptor activator

nuclear factor-κβ

factor-κβ ligand

ligand targeting

targeting ranked

ranked immuno-oncology

immuno-oncology target

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!